Saturday 17 October 2026
Export IRIX’s income statement to Excel — free account
IRIDEX Corporation
IRIX Healthcare Medical Devices
IRIDEX Corporation’s revenue for fiscal 2025 (year ended December 2025) was $52.7 million, up 8.23% from fiscal 2024. In the quarter to June 2026, revenue fell 7.41%, EPS fell 16.7%, free cash flow grew 130.2% and total debt rose 3.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.81
0.01
−1.22%
Follow IRIX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 4 | 4 |
+8 more TTM periods Free account |
| 308.17% | 1,574.52% | (870.85%) | (780.21%) | ||
| (12.06%) | (10.48%) | (15.22%) | (17.39%) | ||
ROIC |
(63.07%) | (43.09%) | (61.12%) | (67.92%) | |
Return on Tangible Assets |
(32.34%) | (27.53%) | (36.66%) | (43.49%) | |
Average Days of Receivables |
50.17 | 58.42 | 66.14 | 68.68 | |
Free Cash Flow per Share |
(0.11) | (0.15) | (0.13) | (0.23) | |
Free Cash Flow |
(2.00) | (2.53) | (2.26) | (3.99) | |
Capital Expenditures |
(0.27) | (0.23) | (0.14) | (0.05) | |
| Other line items | |||||
Cash ROIC |
(16.51%) | (19.36%) | (15.38%) | (28.57%) | |
Accounts Receivable Turnover |
6.03 | 5.91 | 5.87 | 5.85 | |
Accounts Payable Turnover |
5.52 | 5.71 | 5.41 | 5.90 | |
Inventory Turnover |
3.63 | 3.46 | 3.58 | 3.43 | |
Average Days of Payables |
73.45 | 62.37 | 58.76 | 51.40 | |
Days of Inventory on Hand |
107.71 | 101.10 | 85.96 | 85.11 | |
Tax Rate |
0.04 | 0.03 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
7.29% | 7.03% | 6.96% | 7.57% | |
Selling, General and Administrative Expense of Revenue |
34.02% | 34.06% | 34.42% | 36.65% | |
Share Based Compensation of Revenue |
1.41% | 1.47% | 1.47% | 1.73% | |
Operating CF/Net income |
0.49 | 0.70 | 0.48 | 0.77 | |
Depreciation/Fixed assets |
9.02 | 11.94 | 29.59 | 76.13 | |
Capex/Depreciation |
(0.16) | (0.14) | (0.08) | (0.03) | |
Revenue per Share |
2.96 | 3.04 | 3.11 | 2.98 | |
Operating CF per Share |
(0.10) | (0.13) | (0.12) | (0.23) | |
Capex per Share |
(0.02) | (0.01) | (0.01) | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 |
Columns are period end dates